Literature DB >> 19517153

Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging.

Alexander L Klibanov1.   

Abstract

Targeted ultrasound contrast agents can be prepared by attaching targeting ligands to the lipid, protein or polymer shell coating of gas-filled microbubbles. These materials are stable on storage, fully biocompatible and can be administered parenterally. Detection of microbubble contrast agents by ultrasound is very efficient (single particles with picogram mass can be visualized). Covalent or noncovalent binding techniques can be used to attach targeting ligands. Ligand-carrying microbubbles adhere to the respective molecular targets in vitro and in vivo. Several biomechanical methods are available to improve targeting efficacy, such as the use of a flexible tether spacer arm between the ligand and the bubble, and the use of folds on the microbubble shell, that project out, enhancing the contact area and increasing the length of the lever arm.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19517153     DOI: 10.1007/s11517-009-0498-0

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  48 in total

Review 1.  Microbubbles in medical imaging: current applications and future directions.

Authors:  Jonathan R Lindner
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

2.  Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow.

Authors:  A L Klibanov; J J Rychak; W C Yang; S Alikhani; B Li; S Acton; J R Lindner; K Ley; S Kaul
Journal:  Contrast Media Mol Imaging       Date:  2006 Nov-Dec       Impact factor: 3.161

3.  Selectin ligands promote ultrasound contrast agent adhesion under shear flow.

Authors:  J J Rychak; B Li; S T Acton; A Leppänen; R D Cummings; K Ley; A L Klibanov
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

4.  Polymeric ultrasound contrast agents targeted to integrins: importance of process methods and surface density of ligands.

Authors:  Margaret A Wheatley; Justin D Lathia; Kelleny L Oum
Journal:  Biomacromolecules       Date:  2007-02       Impact factor: 6.988

5.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.

Authors:  Kyosuke Yanagisawa; Fuminori Moriyasu; Takeo Miyahara; Miyata Yuki; Hiroko Iijima
Journal:  Ultrasound Med Biol       Date:  2007-02       Impact factor: 2.998

6.  Phase I clinical trials of MRX-115. A new ultrasound contrast agent.

Authors:  T A Fritz; E C Unger; G Sutherland; D Sahn
Journal:  Invest Radiol       Date:  1997-12       Impact factor: 6.016

7.  Comparison of PSGL-1 microbead and neutrophil rolling: microvillus elongation stabilizes P-selectin bond clusters.

Authors:  Eric Y H Park; McRae J Smith; Emily S Stropp; Karen R Snapp; Jeffrey A DiVietro; William F Walker; David W Schmidtke; Scott L Diamond; Michael B Lawrence
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

8.  Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx.

Authors:  Gregory E R Weller; Flordeliza S Villanueva; Eric M Tom; William R Wagner
Journal:  Biotechnol Bioeng       Date:  2005-12-20       Impact factor: 4.530

9.  Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface.

Authors:  T M Allen; P Williamson; R A Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.

Authors:  F S Villanueva; R J Jankowski; S Klibanov; M L Pina; S M Alber; S C Watkins; G H Brandenburger; W R Wagner
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

View more
  39 in total

Review 1.  MR-guided focused ultrasound surgery, present and future.

Authors:  David Schlesinger; Stanley Benedict; Chris Diederich; Wladyslaw Gedroyc; Alexander Klibanov; James Larner
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

2.  An optical system for detecting 3D high-speed oscillation of a single ultrasound microbubble.

Authors:  Yuan Liu; Baohong Yuan
Journal:  Biomed Opt Express       Date:  2013-08-08       Impact factor: 3.732

Review 3.  Mechanisms of microbubble-facilitated sonoporation for drug and gene delivery.

Authors:  Zhenzhen Fan; Ronald E Kumon; Cheri X Deng
Journal:  Ther Deliv       Date:  2014-04

4.  Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury.

Authors:  Kenneth Hoyt; Jason M Warram; Dezhi Wang; Sithira Ratnayaka; Amie Traylor; Anupam Agarwal
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

5.  Special issue on microbubbles: from contrast enhancement to cancer therapy.

Authors:  Eleanor Stride; Mohan Edirisinghe
Journal:  Med Biol Eng Comput       Date:  2009-07-28       Impact factor: 2.602

Review 6.  Focused ultrasound surgery in oncology: overview and principles.

Authors:  Clare M C Tempany; Nathan J McDannold; Kullervo Hynynen; Ferenc A Jolesz
Journal:  Radiology       Date:  2011-04       Impact factor: 11.105

Review 7.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.

Authors:  Natalya Rapoport
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-06-22

Review 8.  A novel technology: microfluidic devices for microbubble ultrasound contrast agent generation.

Authors:  Hangyu Lin; Junfang Chen; Chuanpin Chen
Journal:  Med Biol Eng Comput       Date:  2016-03-25       Impact factor: 2.602

9.  Ultrasound for molecular imaging and therapy in cancer.

Authors:  Osamu F Kaneko; Jürgen K Willmann
Journal:  Quant Imaging Med Surg       Date:  2012-06

10.  Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts.

Authors:  Caixiu Pu; Jiangchuan Sun; Shenyin Zhu; Shufang Chang; Hongxia Liu; Yi Zhu; Zhigang Wang; Ronald X Xu
Journal:  Mol Pharm       Date:  2013-11-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.